POSTOPERATIVE HYPOFRACTIONATED ACCELERATED INTENSITY MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN THE MANAGEMENT OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS OF A PILOT STUDY

被引：0
|
作者：
Biswas, A. [1 ]
Julka, P. K. [1 ]
Sharma, S. [1 ]
Binjola, A. [1 ]
Laviraj, M. A. [1 ]
Sarkar, C. [1 ]
Rath, G. K. [1 ]
机构：
[1] All India Inst Med Sci, New Delhi, India
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P08.10
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Ney, Douglas
    Waziri, Allen
    Lillehei, Kevin
    Kavanagh, Brian D.
    [J]. NEURO-ONCOLOGY, 2011, 13 : 128 - 128
  • [2] Hypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiforme
    Ammirati, Mario
    Chotai, Silky
    Newton, Herbert
    Lamki, Tarig
    Wei, Lai
    Grecula, John
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (04) : 633 - 637
  • [3] Accelerated hypofractionated intensity modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: A safety and efficacy analysis
    Panet-Raymond, V.
    Roberge, D.
    Sonhami, L.
    Shakibnia, L.
    Kavan, P.
    Muanza, T.
    Lambert, C.
    Guiot, M. C.
    Shenouda, G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S245 - S246
  • [4] ACCELERATED HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME: A SAFETY AND EFFICACY ANALYSIS
    Panet-Raymond, Valerie
    Souhami, Luis
    Roberge, David
    Kavan, Petr
    Shakibnia, Lily
    Muanza, Thierry
    Lambert, Christine
    Leblanc, Richard
    Del Maestro, Rolando
    Guiot, Marie-Christine
    Shenouda, George
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (02): : 473 - 478
  • [5] Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients over 70 Years Old with Newly Diagnosed Glioblastoma
    Yusuf, Mehran
    Ugiliweneza, Beatrice
    Amsbaugh, Mark
    Boakye, Maxwell
    Williams, Brian
    Nelson, Megan
    Hattab, Eyas M.
    Woo, Shiao
    Burton, Eric
    [J]. ONCOLOGY, 2018, 95 (01) : 39 - 42
  • [6] FINAL RESULTS OF A PHASE II STUDY OF HYPOFRACTIONATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN PATIENTS OVER 70 YEARS OLD WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Yusuf, Mehran
    Gaskins, Jeremy
    Woo, Shiao
    Burton, Eric
    [J]. NEURO-ONCOLOGY, 2019, 21 : 12 - 12
  • [7] Hypofractionated Accelerated Radiotherapy With Concurrent And Maintenance Temozolomide In Newly Diagnosed Glioblastoma- Updated Results Of A Phase 2 Trial
    Rath, G. K.
    Mallick, S.
    Kunhiparambath, H.
    Gupta, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E702 - E703
  • [8] The efficacy of hypofractionated radiotherapy (HFRT) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: A meta-analysis
    Guo, Longbin
    Li, Xuanzi
    Chen, Yulei
    Liu, Rongping
    Ren, Chen
    Du, Shasha
    [J]. CANCER RADIOTHERAPIE, 2021, 25 (02): : 182 - 190
  • [9] A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients
    Pan, Edward
    Mitchell, Susan B.
    Tsai, Jerry S.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (03) : 353 - 357
  • [10] A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients
    Edward Pan
    Susan B. Mitchell
    Jerry S. Tsai
    [J]. Journal of Neuro-Oncology, 2008, 88 : 353 - 357
12345